publication date: Dec. 19, 2010
In this issue:
FDA approves Gemzar for ovarian cancer, contradicting ODAC recommendation; continues agency trend to recognize progression-free survival as an endpoint.
FDA official says acceptance of PFS “brings us in line with our European colleagues.”
NCI says sponsored meetings must be held in smoke-free localities as of Jan. 1.
ACS presents awards to anti-tobacco activists.
Download (PDF 763KB)
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.